« Back

Travere Therapeutics to Present at Upcoming Investor Conferences

Nov 11, 2021

SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that management will present a Company overview at the following upcoming virtual investor conferences in November:

Jefferies 2021 London Healthcare Conference
Date: Thursday, November 18, 2021
Time: On-demand webcast available beginning 8:00 a.m. GMT (3:00 a.m. ET)

4th Annual Evercore ISI HealthCONx Conference
Date: Tuesday, November 30, 2021
Time: 10:30 a.m. ET

Live webcasts will be available at and archived replays will be accessible for up to 30 days.

About Travere Therapeutics

At Travere Therapeutics, we are in rare for life. We are a biopharmaceutical company that comes together every day to help patients, families and caregivers of all backgrounds as they navigate life with a rare disease. On this path, we know the need for treatment options is urgent – that is why our global team works with the rare disease community to identify, develop and deliver life-changing therapies. In pursuit of this mission, we continuously seek to understand the diverse perspectives of rare patients and to courageously forge new paths to make a difference in their lives and provide hope – today and tomorrow. For more information, visit

Chris Cline, CFA                                 
Senior Vice President, Investor Relations & Corporate Communications


Primary Logo

Source: Travere Therapeutics, Inc.